Table 1.
Time | Localization | Event | Consequences | Reference |
---|---|---|---|---|
6 h | costamere | loss of melusin | increased FoxO3-independent transcription of MAFbx-Atrogin-1 | [128] |
redistribution of non-muscle α-actinin and β- and γ- actin |
subsarcolemmal cytoskeleton reorganization | [229,230] | ||
loss of active sarcolemmal nNOS | FoxO3 nuclear translocation | [30] | ||
decreased sarcolemmal NO production | AMPK inactivity | [20] | ||
sarcoplasm | increased accumulation of active/uncoupled nNOS | increased NO/ROS production | [30] | |
mitochondria | ROS production | loss of active sarcolemmal nNOS | [30] | |
ROS production | covalent S-S tropomyosin species | [30] | ||
sarcolemma | loss of cholesterol | membrane instability loss of Na/K pump activity |
[210,231] | |
inhibition of 2subunit of Na/K pump | membrane instability | [231] | ||
nucleus | increased FoxO3 localization | transcriptional activity | [30] | |
decreased nNOS transcription | decreased nNOS protein | [30] | ||
12 h | sarcoplasm | AMPK inactivity | p70S6K activation loss of Na/K pump activity | [20,211] |
ceramide accumulation | sarcolemma instability | [210] | ||
increased phospo-p70S6K | pSer-IRS-1 | [20,31] | ||
24 h | sarcolemma/costamere | decreased levels of IRS-1 | impaired Akt activation | [31] |
decreased integrin signaling activation | impaired Akt, ERK1/2 activation | [31,128] | ||
nucleus | increased FoxO3 transcription | increased protein levels and atrogene upregulation | [31,68,128,227] | |
myosin gene down-regulation | fiber type transition | [2] | ||
multiple transcriptional changes | phenotype change | [68] | ||
sarcoplasm/nucleus | increased p53 protein levels | MuRF-1 and p21 upregulation | [57] | |
48 h | SR/ER | decreased Grp94/gp96 levels | decreased nNOS delivery to sarcolemma | [30] |
sarcoplasm | increased protein ubiquitination and deacetylation by HDAC1 | increased protein catabolism, FoxO3 activation | [32,227] | |
increased Bax/Bcl2 ratio; mitochondrial release of AIF; caspase -3 and caspase-8 activation | increased myonuclei apoptosis | [73] | ||
reduced myofiber cross-sectional area | earliest morphological evidence of muscle atrophy | [30] |